Letko, Brosseau & Associates Inc Aura Biosciences, Inc. Transaction History
Letko, Brosseau & Associates Inc
- $4.6 Billion
- Q1 2025
A detailed history of Letko, Brosseau & Associates Inc transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Letko, Brosseau & Associates Inc holds 21,200 shares of AURA stock, worth $116,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,200
Previous 21,200
-0.0%
Holding current value
$116,600
Previous $174,000
28.74%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AURA
# of Institutions
95Shares Held
40.4MCall Options Held
6KPut Options Held
6.4K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$38.1 Million12.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$26.8 Million0.06% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR3.32MShares$18.3 Million0.67% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$16.7 Million4.98% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$16.5 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $161M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...